Skip to main content

ORIGINAL RESEARCH article

Front. Aging Neurosci.

Sec. Parkinson’s Disease and Aging-related Movement Disorders

Volume 17 - 2025 | doi: 10.3389/fnagi.2025.1510654

This article is part of the Research Topic Advances in Parkinson's Disease Research: Exploring Biomarkers and Therapeutic Strategies for Halting Disease Progression View all 20 articles

Reduced Composite Dietary Antioxidant Index Increases the Risk of Parkinson's Disease and All-Cause Mortality in Parkinson's Disease Patients: Evidence from the NHANES Database

Provisionally accepted
Fei Huang Fei Huang Jingwen Hao Jingwen Hao Chanjuan Chen Chanjuan Chen Qun Liu Qun Liu Dan He Dan He *
  • The First Hospital of Changsha, Changsha, China

The final, formatted version of the article will be published soon.

    Background: This study aimed to investigate the relationship between the Composite Dietary Antioxidant Index (CDAI) and the prevalence of Parkinson's disease (PD), as well as to explore its relationship with all-cause mortality risk in PD patients.Methods: Data from the National Health and Nutrition Examination Survey (NHANES) database spanning from 2007 to 2018 were used, including 119,609 participants. After excluding individuals aged <18 years, those with incomplete follow-up data, and those missing critical variables such as CDAI and covariates, the final cohort consisted of 34,133 participants. Participants were categorized into a PD group (510 individuals) and a non-PD group (33,623 individuals). The CDAI values were calculated, and participants were divided into three groups based on the tertile distribution of their CDAI scores: Q1(CDAI < -1.07), Q2 (-1.07 to 1.74), and Q3 (CDAI >1.74). Weighted logistic regression and weighted Cox regression analyses were employed to evaluate the associations between CDAI and the prevalence of PD, as well as between CDAI and all-cause mortality risk. Restricted cubic spline regression analysis was used to further elucidate the precise relationship between CDAI and outcome events.Results: CDAI values were significantly lower in the PD group compared to the non-PD group. After adjusting for age, sex, comorbid conditions (hypertension and diabetes), blood lipid and glucose levels, a reduction in CDAI was associated with an increased risk of PD (Q vs Q1, OR=0.72, P=0.035). In patients with PD, a decrease in CDAI was significantly associated with a higher risk of all-cause mortality (Q3 vs Q1, HR=0.53, P=0.018). This association was particularly pronounced in those over 60 years old, smokers, and those with hypertension. Restricted cubic spline regression analysis identified CDAI <0.471 as a risk factor for PD, and CDAI <0.527 as a risk factor for all-cause mortality in PD patients.CDAI reduction is an independent risk factor for both PD risk in the general population and all-cause mortality in PD patients, with amplified predictive power in older adults, smokers, and hypertensive individuals. Our findings support developing personalized antioxidant-enhancing nutritional interventions for both high-risk populations with suboptimal CDAI and established PD patients.

    Keywords: Parkinson's disease, NHANES database, Composite Dietary Antioxidant Index, All-cause mortality, restricted cubic spline regression model. Article types: Original Research

    Received: 13 Oct 2024; Accepted: 18 Feb 2025.

    Copyright: © 2025 Huang, Hao, Chen, Liu and He. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Dan He, The First Hospital of Changsha, Changsha, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    People also looked at

    Research integrity at Frontiers

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more